P
US11040139B2ActiveUtilityPatentIndex 62

Drug delivery systems with sealed and sterile fluid paths and methods of providing the same

Assignee: INSULET CORPPriority: Nov 11, 2016Filed: Feb 4, 2020Granted: Jun 22, 2021
Est. expiryNov 11, 2036(~10.4 yrs left)· nominal 20-yr term from priority
Inventors:MCLAUGHLIN IAN
A61L 2103/23A61L 2/206A61M 5/162A61L 2/081A61L 2/082A61L 2/087A61L 2/07A61M 5/16827A61M 5/001A61M 5/2466A61L 2/00A61M 2005/3118A61M 2039/1072A61M 2005/3132A61M 2005/3258A61M 5/19A61M 5/14566A61L 2202/23
62
PatentIndex Score
0
Cited by
48
References
20
Claims

Abstract

The present disclosure relates generally to the field of drug delivery. In particular, the present disclosure relates to a drug delivery system that includes a sealed and sterile fluid path attached to a drug-loaded container. The disclosure further relates to methods for sterilizing a portion of the drug delivery system without exposing the drug-loaded container to harmful sterilization parameters.

Claims

exact text as granted — not AI-modified
The invention claimed is: 
     
       1. A method, comprising:
 providing an energy source and a drug delivery system; and 
 positioning a shield between the energy source and the drug delivery system, the drug delivery system comprising a container, a fluid path, and a cover, wherein the container holds a liquid drug, wherein a first end of the fluid path is disposed within the container, and wherein a second end of the fluid path is disposed within the cover. 
 
     
     
       2. The method of  claim 1 , further comprising:
 emitting energy from the energy source; 
 sterilizing the fluid path by exposing the fluid path to the energy emitted by the energy source; and 
 blocking exposure of the liquid drug to a substantial portion of the energy emitted by the energy source. 
 
     
     
       3. The method of  claim 2 , further comprising sterilizing the liquid drug prior to sterilizing the fluid path. 
     
     
       4. The method of  claim 1 , wherein positioning the shield comprises positioning an aluminum shield having a thickness of at least 30 mm between the drug delivery system and the energy source. 
     
     
       5. The method of  claim 1 , further comprising piercing a cap sealing the container with the first end of the fluid path to couple the liquid drug to the fluid path. 
     
     
       6. The method of  claim 1 , further comprising piercing a septum sealing the container with the first end of the fluid path to couple the liquid drug to the fluid path. 
     
     
       7. The method of  claim 1 , further comprising piercing a plunger sealing the container with the first end of the fluid path to couple the liquid drug to the fluid path. 
     
     
       8. The method of  claim 1 , wherein positioning the shield comprises placing the fluid path and the container within a first shield component having an exposure window and coupling a second shield component to the first shield component. 
     
     
       9. A method for sterilizing a liquid drug in a drug delivery system, comprising:
 positioning a shield between an energy source and the drug delivery system, the drug delivery system comprising a fluid path and a container holding the liquid drug; and 
 exposing the fluid path to an energy emitted by the energy source, wherein the shield blocks exposure of the liquid drug to at least a portion of the energy. 
 
     
     
       10. The method of  claim 9 , further comprising sterilizing the liquid drug prior to sterilizing the fluid path. 
     
     
       11. The method of  claim 9 , wherein positioning the shield comprises positioning an aluminum shield having a thickness of at least 30 mm between the drug delivery system and the energy source. 
     
     
       12. The method of  claim 9 , further comprising piercing a cap sealing the container with the fluid path to couple the liquid drug to the fluid path upon activation by a user. 
     
     
       13. The method of  claim 9 , further comprising piercing a septum sealing the container with the fluid path to couple the liquid drug to the fluid path upon activation by a user. 
     
     
       14. The method of  claim 9 , further comprising piercing a plunger sealing the container with the fluid path to couple the liquid drug to the fluid path upon activation by a user. 
     
     
       15. The method of  claim 9 , wherein positioning the shield comprises placing the fluid path and the container within a first shield component having an exposure window and coupling a second shield component to the first shield component. 
     
     
       16. A method, comprising:
 positioning a shield between an energy source and a drug delivery system, the drug delivery system comprising a fluid path for accessing a liquid drug within a container; and 
 exposing the fluid path to an energy emitted by the energy source, wherein the shield blocks exposure of the liquid drug to at least a portion of the energy. 
 
     
     
       17. The method of  claim 16 , further comprising blocking exposure, by the energy emitted from the energy source, of an entire portion of the container and at least a portion of a cap inserted within the container. 
     
     
       18. The method of  claim 17 , further comprising piercing the cap with the fluid path to couple the liquid drug to the fluid path upon activation by a user. 
     
     
       19. The method of  claim 16 , further comprising exposing an entire portion of the fluid path to the energy emitted by the energy source. 
     
     
       20. The method of  claim 16 , wherein positioning the shield comprises placing the fluid path and the container within a first shield component having an exposure window and coupling a second shield component to the first shield component.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.